OR WAIT null SECS
© 2024 MJH Life Sciences and BioPharm International. All rights reserved.
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Jay Wealand is a principal scientist at Pfizer BioTherapeutics Research and Development
New technologies and adaptations of existing technologies can improve platform processes.